The use of monitoring equipment to measure various physical parameters of a patient is well known. There is a growing demand for using subcutaneous monitoring devices, which allow doctors to obtain information without a patient being connected to an external machine and/or which may otherwise not be reproducible in office settings. The term subcutaneous generally implies locations within the body of a patient under the skin and exterior to the musculature beneath the skin. For example, an implantable device that includes the ability to monitor a patient's heart beat in order to detect transient symptoms suggesting cardiac arrhythmia allows doctors to review data over a longer period of time than using external monitoring equipment in a simulated testing situation. However, to successfully implant implantable subcutaneous devices an implantation tool should, for example, ensure that the device is not implanted in muscle, reduce contact between the surgeon and the wound, be used in an office setting to minimize patient discomfort and the need for invasive surgery and have the ability to repeatedly recreate the same size incision site in the patient.
Exemplary prior art insertion tools include those illustrated in US Patent Application Publication No. 2010/0094252 by Wengreen, et al., incorporated herein by reference in its entirety.
Further areas of applicability will become apparent from the description provided herein. It should be understood that the description and specific examples are intended for purposes of illustration only and are not intended to limit the scope of the present disclosure.
Exemplary embodiments provide subcutaneous implantation tools and methods of implanting a subcutaneous micro-device using the same. The invention provides a syringe-like tool, comprising a tool body, hereafter “handle”, having a hollow, distally longitudinally extending recess such as a bore or channel and having a distal opening through which the device may be delivered. The device preferably also includes a movable plunger located within the bore or channel. An incision tool is provided to make an incision through which the subcutaneous device is implanted.
The device may, for example, be implanted in the region of the thorax. A specific recommended location will typically be provided within an associated product manual. In one embodiment, two electrodes on the body of the device monitor the patient's subcutaneous ECG. The device may ECG recordings in response to patient activation or in response to automatically detected arrhythmias. Exemplary devices are disclosed in US Patent Application Publication No. 2009/0036917 by Anderson, US Patent Application Publication No. 2010/0094252 by Wengreen, et al., US Patent Application Publication No. 2012/0283705 by Hoeppner, et al., U.S. Pat. No. 5,987,352, issued to Klein, et al., U.S. Pat. Nos. 6,412,490 and 7,035,684 issued to Lee, et al. and U.S. Pat. No. 6,230,059, issued to Duffin, et al., all incorporated herein by reference in their entireties.
The incision tool is designed to create an incision of repeatable width and depth with a single motion. It is composed of a blade, designed to make a repeatable incision, and handle, designed to ergonomically fit the hand. The incision tool is intended to make the incision simple and repeatable. Other mechanisms for making openings in the patient's skin such as trocars, spreaders, scalpels and the like may be substituted in some alternative embodiments. The insertion tool delivers the device through the incision and into the subcutaneous tissue. The tool is designed to ensure the device is delivered into a tight pocket to maximize electrode contact with the surrounding tissue in a highly repeatable manner, and is composed of two parts: a handle and a plunger. The handle is composed of a bore or channel section, used to hold the device and guide it during implant, and a protrusion extending distally of the channel, used to bluntly dissect an implant path for the device to travel down while being implanted. The tunneler extends distally from the channel a position laterally displaced from the device when the device is located in the channel. The plunger is used to push the device distally out of the handle, through the incision, alongside and exterior to the tunneler and along the implant path created by the tunneler to the final implant location.
The device is typically loaded into the channel section of the insertion tool handle and sterile packaged along with both the insertion tool plunger and the incision tool.
The device is locatable within the channel distal to the plunger, so that when the plunger is moved distally, the device advances distally out of the tool body and into the tissue. Typically, the device will take the form of an elongated body, having a length greater than its thickness and width, as illustrated in the published Application No. 2010/0094252, cited above. The device may extend along its longitudinal axis between proximal and distal ends. The longitudinal channel or bore of the tool body may conform at least in part to the outer configuration of the device and more typically to a cross section of the device taken along its longitudinal axis. If the device, like the above discussed device, has a width greater than its depth and/or is otherwise radially asymmetric around its longitudinal axis, this feature allows the device to be advanced into the tissue while maintaining a desired orientation, as discussed in more detail below.
Optimally, the final insertion site of the device is located a short distance from the incision site. As noted above, the handle is preferably provided with an elongated protrusion or tunneler extending distally from the distal opening of the bore, which is insertable into the tissue through the incision to create a path in the tissue, along which the device may be advanced when pushed by the plunger. The distal end of the tunneler when so inserted is preferably located at the desired location of the distal end of the device. The length of the tunneler is thus preferably at least equal to and preferably somewhat greater than the length of the subcutaneous device.
Additional embodiments provide methods of implanting a subcutaneous micro-device, including inserting the dissection body of the tool described by the embodiments of the tool into an implantation site, where the dissection body includes a micro-device, and delivering the micro-device.
Exemplary embodiments will be more clearly understood from the following detailed description taken in conjunction with the accompanying drawings.
Various exemplary embodiments will now be described more fully with reference to the accompanying drawings in which some exemplary embodiments are illustrated. In the drawings, the thicknesses of layers and regions may be exaggerated for clarity.
Accordingly, while exemplary embodiments are capable of various modifications and alternative forms, embodiments thereof are shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that there is no intent to limit exemplary embodiments to the particular forms disclosed, but on the contrary, exemplary embodiments are to cover all modifications, equivalents, and alternatives falling within the scope of the invention. Like numbers refer to like elements throughout the description of the figures.
It will be understood that, although the terms first, second, etc. may be used herein to describe various elements, these elements should not be limited by these terms. These terms are only used to distinguish one element from another. For example, a first element could be termed a second element, and, similarly, a second element could be termed a first element, without departing from the scope of exemplary embodiments. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items.
It will be understood that when an element is referred to as being “connected” or “coupled” to another element, it can be directly connected or coupled to the other element or intervening elements may be present. In contrast, when an element is referred to as being “directly connected” or “directly coupled” to another element, there are no intervening elements present. Other words used to describe the relationship between elements should be interpreted in a like fashion (e.g., “between” versus “directly between,” “adjacent” versus “directly adjacent,” etc.).
The terminology used herein is for the purpose of describing only particular embodiments and is not intended to be limiting of exemplary embodiments. As used herein, the singular forms “a,” “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises,” “comprising,” “includes” and/or “including,” when used herein, specify the presence of stated features, integers, steps, operations, elements and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components and/or groups thereof.
Spatially relative terms, e.g., “beneath,” “below,” “lower,” “above,” “upper” and the like, may be used herein for ease of description to describe one element or a relationship between a feature and another element or feature as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the Figures. For example, if the device in the figures is turned over, elements described as “below” or “beneath” other elements or features would then be oriented “above” the other elements or features. Thus, for example, the term “below” can encompass both an orientation which is above as well as below. The device may be otherwise oriented (rotated 90 degrees or viewed or referenced at other orientations) and the spatially relative descriptors used herein should be interpreted accordingly.
It should also be noted that in some alternative implementations, the functions/acts noted may occur out of the order noted in the figures. For example, two figures shown in succession may in fact be executed substantially concurrently or may sometimes be executed in the reverse order, depending upon the functionality/acts involved.
Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which exemplary embodiments belong. It will be further understood that terms, e.g., those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
Exemplary embodiments are directed to subcutaneous implantation tools and methods of implanting subcutaneous micro-devices.
The exemplary device 10 as illustrated generally takes the form of an elongated rectangular prism having rounded corners and a rounded distal end portion. The rounded distal end of the device assists in allowing it to advance into body tissue, providing blunt dissection of the tissue as it advances. Because the cross section of the device is substantially greater than the cross section of the tunneler, the device will be located snugly within the tissue, reducing the chances for the formation of air bubbles adjacent the electrodes and also assisting in maintaining the device in its desired position. The device has length (L), width (W) and depth (D) as illustrated. In this particular embodiment, the with is greater than the depth, providing radial asymmetry along the longitudinal axis of the device and assisting in maintaining the device in its proper orientation with upper surface 16 facing outward after implant. A suture hole 18 may optionally be provided at the proximal end of the device to allow the physician to suture it to underlying tissue if desired. Projections 22 may optionally be provided to prevent longitudinal movement of the device after implant.
As discussed above, the inner surface of the channel of the handle is preferably configured to correspond to the outer configuration of the device. As discussed below in more detail, the configuration of the channel of the handle is configured to engage the rounded corners of the device, preventing rotation of the device within the handle.
The plunger is provided with a groove 306 running the length of the lower surface of the plunger up to a distal stop surface discussed below. The opening in the proximal end of the handle includes a protrusion corresponding to the groove in the lower surface of the plunger, assuring its proper orientation within the handle. A marking 308 adjacent the proximal end of the plunger assists the physician in determining that the plunger is in the proper orientation for insertion into the handle.
The plunger is advanced distally, pushing the device into the incision along the then inward facing surface of the tunneler. The device thus follows the path defined by the tunneler to assure proper placement within the tissue. After insertion of the device, the handle and plunger are removed.
Various medical grade materials may be used to form the various parts of the subcutaneous implantation tool, for example, plastics, metals, rubber, sanitizable materials, etc. Exemplary embodiments of the subcutaneous implantation tool may be inexpensive, disposable, etc. The subcutaneous implantation tool may also be configured to be used with known automated injection systems, which use, e.g., compressed air or other inert gases in place of a manual plunger.
Exemplary embodiments thus described allow for subcutaneous implantation of devices that are minimally invasive. Note that exemplary embodiments may be used in both human and animal patients.
Exemplary embodiments of the present invention being thus described, it will be obvious that the same may be varied in many ways. Such variations are not to be regarded as a departure from the spirit and scope of the exemplary embodiments of the invention, and all such modifications as would be obvious to one skilled in the art are intended to be included within the scope of the invention.
This application is a continuation of U.S. patent application Ser. No. 15/610,076, filed May 31, 2017, which is a continuation of U.S. patent application Ser. No. 14/204,227, filed Mar. 11, 2014, which claims the benefit of U.S. Provisional Application No. 61/788,940, filed Mar. 15, 2013. The entire content of each of these applications is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2009393 | Gioacchino | Jul 1935 | A |
2647512 | Johnson | Aug 1953 | A |
4915686 | Frederick | Apr 1990 | A |
5127404 | Wyborny et al. | Jul 1992 | A |
5304119 | Balaban et al. | Apr 1994 | A |
5484403 | Yoakum et al. | Jan 1996 | A |
5507807 | Shippert | Apr 1996 | A |
5562613 | Kaldany | Oct 1996 | A |
5772671 | Harmon | Jun 1998 | A |
5842999 | Pruitt et al. | Dec 1998 | A |
5954670 | Baker | Sep 1999 | A |
5987352 | Klein et al. | Nov 1999 | A |
6230059 | Duffin | May 2001 | B1 |
6412490 | Lee | Jul 2002 | B1 |
7035684 | Lee | Apr 2006 | B2 |
8888745 | Van Der Graaf et al. | Nov 2014 | B2 |
10786279 | Vanderpool | Sep 2020 | B2 |
11134986 | Vanderpool | Oct 2021 | B2 |
11241253 | Vanderpool | Feb 2022 | B2 |
20010029386 | Matsutani et al. | Oct 2001 | A1 |
20030088212 | Tal | May 2003 | A1 |
20040082969 | Kerr | Apr 2004 | A1 |
20040143284 | Chin | Jul 2004 | A1 |
20040193154 | Leatherbury et al. | Sep 2004 | A1 |
20040249388 | Michelson | Dec 2004 | A1 |
20050090852 | Layne et al. | Apr 2005 | A1 |
20050096645 | Wellman et al. | May 2005 | A1 |
20050107768 | Ting | May 2005 | A1 |
20060074434 | Wenstrom, Jr. et al. | Apr 2006 | A1 |
20060097331 | Hattori et al. | May 2006 | A1 |
20060106415 | Gabbay | May 2006 | A1 |
20060174898 | Brown | Aug 2006 | A1 |
20070010738 | Mark et al. | Jan 2007 | A1 |
20070179515 | Matsutani et al. | Aug 2007 | A1 |
20070249992 | Bardy | Oct 2007 | A1 |
20080154298 | Grayzel et al. | Jun 2008 | A1 |
20090030426 | Zinn et al. | Jan 2009 | A1 |
20090036917 | Anderson | Feb 2009 | A1 |
20090137946 | Nassiri et al. | May 2009 | A1 |
20100030227 | Kast et al. | Feb 2010 | A1 |
20100094252 | Wengreen et al. | Apr 2010 | A1 |
20100198140 | Lawson | Aug 2010 | A1 |
20100324578 | Bardy | Dec 2010 | A1 |
20100331868 | Bardy | Dec 2010 | A1 |
20110034886 | Elbe et al. | Feb 2011 | A1 |
20120283705 | Lee et al. | Nov 2012 | A1 |
20140128963 | Quill et al. | May 2014 | A1 |
20140276928 | Vanderpool et al. | Sep 2014 | A1 |
20160175007 | Valbuena et al. | Jun 2016 | A1 |
20170258346 | Vanderpool et al. | Sep 2017 | A1 |
20200129206 | Cornelius et al. | Apr 2020 | A1 |
20210153895 | Vanderpool et al. | May 2021 | A1 |
20210267634 | Vanderpool et al. | Sep 2021 | A1 |
20210267635 | Vanderpool et al. | Sep 2021 | A1 |
20210267636 | Vanderpool et al. | Sep 2021 | A1 |
20210275221 | Vanderpool et al. | Sep 2021 | A1 |
Number | Date | Country |
---|---|---|
1031481 | Mar 1989 | CN |
2621634 | Jun 2004 | CN |
2702718 | Jun 2005 | CN |
202342097 | Jul 2012 | CN |
469951 | Jan 1929 | DE |
4243641 | Sep 1994 | DE |
3034128 | Jun 2016 | EP |
2001502937 | Mar 2001 | JP |
2007516031 | Jun 2007 | JP |
2008528084 | Jul 2008 | JP |
2011092065 | May 2011 | JP |
9813091 | Apr 1998 | WO |
2005044116 | May 2005 | WO |
2005060306 | Jun 2005 | WO |
2008016551 | Feb 2008 | WO |
2009018008 | Feb 2009 | WO |
2012098356 | Jul 2012 | WO |
Entry |
---|
Prosecution History from U.S. Appl. No. 14/204,227, dated Nov. 5, 2015 through Sep. 8, 2021, 486 pp. |
Prosecution History from U.S. Appl. No. 17/323,298, dated Sep. 9, 2021, 14 pp. |
Prosecution History from U.S. Appl. No. 17/325,873, dated Sep. 3, 2021, 14 pp. |
Prosecution History from U.S. Appl. No. 17/325,904, dated Aug. 11, 2021 through Aug. 18, 2021, 25 pp. |
Prosecution History from U.S. Appl. No. 17/329,986, dated Sep. 30, 2021, 17 pp. |
Response to Examination Report from counterpart European Application No. 18188908.0, dated May 26, 2021, filed Sep. 30, 2021, 24 pp. |
Communication pursuant to Article 94(3) EPC from counterpart European Application No. 18188908.0 dated Feb. 3, 2022, 5 pp. |
Response to Examination Report dated Feb. 3, 2022, from counterpart European Application No. 18188908.0, filed May 16, 2022, 22 pp. |
Notice of Allowance from U.S. Appl. No. 14/204,227 dated Nov. 3, 2021, 10 pp. |
Notice of Allowance from U.S. Appl. No. 17/329,986, dated Oct. 21, 2021, 12 pp. |
The Notification of Rejection, and translation thereof, from counterpart Chinese Application No. 2014-80015082.5, dated Nov. 4, 2020, 11 pp. |
Final Office Action from U.S. Appl. No. 14/204,227, dated Nov. 20, 2020, 41 pp. |
Examination Report from counterpart European Application No. 18188908.0, dated May 26, 2021, 7 pp. |
Prosecution History from U.S. Appl. No. 14/204,227, dated Nov. 5, 2015 through May 10, 2021, 461 pp. |
U.S. Appl. No. 17/323,298, filed May 18, 2021, naming inventors Vanderpool et al. |
U.S. Appl. No. 17/325,873, filed May 20, 2021, naming inventors Vanderpool et al. |
U.S. Appl. No. 17/325,904, filed May 20, 2021, naming inventors Vanderpool et al. |
U.S. Appl. No. 17/329,986, filed May 25, 2021, naming inventors Vanderpool et al. |
U.S. Patent Application No. 29/803, 137, filed Aug. 10, 2021, naming inventors Vanderpool et al. |
U.S. Patent Application No. 29/803, 142, filed Aug. 10, 2021, naming inventors Vanderpool et al. |
Response to Final Office Action dated Nov. 20, 2020, from U.S. Appl. No. 14/204,227, filed Jan. 8, 2021, 18 pp. |
Advisory Action from U.S. Appl. No. 14/204,227, dated Jan. 28, 2021, 5 pp. |
Notice of Appeal and Pre-Appeal Brief Request for Review for U.S. Appl. No. 14/204,227, filed Feb. 8, 2021, 6 pp. |
U.S. Appl. No. 17/165,304, filed Feb. 2, 2021, naming inventors Vanderpool et al. |
First Office Action and Search Report, and translation thereof, from counterpart Chinese Application No. 201480015082.5, dated Mar. 20, 2017, 18 pp. |
Notice on the Second Office Action, and translation thereof, from counterpart Chinese Application No. 201480015082.5, dated Mar. 5, 2018, 9 pp. |
The Decision on Rejection, and translation thereof, from counterpart Chinese Application No. 201480015082.5, dated Dec. 5, 2018, 14 pp. |
Decision on Reexamination from counterpart Chinese Application No. 201480015082.5, dated Sep. 11, 2019, 11 pp. |
Third Office Action, and translation thereof, from counterpart Chinese Application No. 201480015082.5, dated Apr. 7, 2020, 13 pp. |
Fourth Office Action, and translation thereof, from counterpart Chinese Application No. 201480015082.5, dated Jun. 22, 2020, 13 pp. |
Preliminary Amendments filed in counterpart European Patent Application No. 14717919.6, filed on Oct. 9, 2015, 9 pp. |
Communication Pursuant to Rules 161(1) and 162 EPC from counterpart European Application No. 14717919.6, dated Nov. 4, 2015, 2 pp. |
Response to Communication Pursuant to Rules 161(1) and 162 EPC dated Nov. 4, 2015, from counterpart European Application No. 14717919.6, filed May 13, 2016 5 pp. |
Examination Report from counterpart European Application No. 14717919.6, dated Jul. 28, 2017, 5 pp. |
Response to Examination Report dated Jul. 28, 2017, from counterpart European Application No. 14717919.6, filed Dec. 6, 2017, 13 pp. |
Intent to Grant from counterpart European Application No. 14717919.6, dated Apr. 16, 2018, 30 pp. |
Decision to Grant from counterpart European Application No. 14717919.6, dated Jun. 9, 2018, 1 pp. |
Extended European Search Report from counterpart European Patent Application No. 18188908.0, dated Oct. 19, 2018, 7 pp. |
Response to Communication Pursuant to Rule 69 EPC dated Jan. 7, 2019 and the Extended European Search Report dated Oct. 19, 2018, from counterpart European Application No. 18188908.0, filed Apr. 15, 2019, 13 pp. |
Office Action, and translation thereof, from counterpart Japanese Patent Application No. 2016-501382, dated Oct. 29, 2017, 7 pp. |
Decision to Grant, and translation thereof, from counterpart Japanese Application No. 2016-501382, dated Jun. 26, 2018, 5 pp. |
Notice of Reasons for Refusal, and translation thereof, from counterpart Japanese Application No. 2018-137778, dated Jun. 25, 2019, 15 pp. |
Notice of Reasons for Refusal, and translation thereof, from counterpart Japanese Application No. 2018-137778, dated Jun. 28, 2019, 12 pp. |
Office Action, and translation thereof, from counterpart Japanese Application No. 2018137778, dated Feb. 6, 2020, 3 pp. |
International Search Report and the Written Opinion from International Application No. PCT/US2014/023912, dated Jun. 20, 2014, 9 pp. |
International Preliminary Report on Patentability from International Application No. PCT/US2014/023912, dated Sep. 15, 2015, 5 pp. |
Prosecution History from U.S. Appl. No. 14/204,227, dated Nov. 5, 2015 through Aug. 3, 2020, 332 pp. |
Prosecution History from U.S. Appl. No. 15/610,076, dated Aug. 7, 2017 through Aug. 3, 2020, 227 pp. |
U.S. Appl. No. 29/748,593, filed Aug. 31, 2020, naming inventors Vanderpool et al. |
U.S. Appl. No. 29/748,588, filed Aug. 31, 2020, naming inventors Vanderpool et al. |
Office Action from U.S. Appl. No. 17/165,304 dated Feb. 2, 2023, 15 pp. |
Notice of Allowance from U.S. Appl. No. 17/165,304 dated Jun. 1, 2023, 10 pp. |
Notice of Intent to Grant and Text Intended to Grant from counterpart European Application No. 18188908.0 dated Mar. 15, 2023, 36 pp. |
Response to Office Action dated Feb. 2, 2023 from U.S. Appl. No. 17/165,304, filed May 2, 2023, 11 pp. |
Number | Date | Country | |
---|---|---|---|
20200383702 A1 | Dec 2020 | US |
Number | Date | Country | |
---|---|---|---|
61788940 | Mar 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15610076 | May 2017 | US |
Child | 17000688 | US | |
Parent | 14204227 | Mar 2014 | US |
Child | 15610076 | US |